Alzamend Neuro, Inc. (ALZN) vs IMMURON (IMRN)

Alzamend Neuro, Inc. and IMMURON are both Biotechnology companies. Alzamend Neuro, Inc. and IMMURON are of similar size ($9.6M and $8.8M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, IMMURON leads on 6 and Alzamend Neuro, Inc. on 3.

Valuation

Metric ALZN IMRN Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.41 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.93 0.74
EV/Sales n/m (3.50) 10.73
Earnings yield (125.68%) (1.75%) (28.84%)
Free cash flow yield (87.16%) 0.00% (23.03%)

Profitability

Metric ALZN IMRN Biotechnology median
Gross margin 0.00% 71.28% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (262.71%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) 0.00% (57.72%)
Return on assets (122.36%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALZN IMRN Biotechnology median
Revenue growth (TTM) — (6.62%) 5.64%
EPS growth (last fiscal year) 76.77% 37.29% —
Revenue growth, 5-year CAGR — 116.96% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN IMRN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 7.17 4.73
Net debt to EBITDA 0.08 2.25 0.96

Dividend

Metric ALZN IMRN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALZN IMRN Biotechnology median
Market cap 8.78m 9.60m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack